Showing results (131-140 of 157) with videos related to
Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|November 19, 2011
Lead optimisation of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Sarah King, Bryan Roberts, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Andrew Cook, Sarah King, et al.Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Novel inhibitors of the alphavbeta3 integrin--lead identification strategyDavid Elliot, Eleanor Henshaw, Philip A MacFaul, et al.Journal of Chemical Information and Computer Sciences|March 23, 2004
Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compoundsN Baurin, R Baker, C Richardson, et al.Plos One|January 6, 2012
Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasisRichard L Mort, Adam J Bentley, Francis L Martin, et al.Tissue Engineering. Part A|April 16, 2020
Oxygen Plasma Substrate and Specific Nanopattern Promote Early Differentiation of HepaRG ProgenitorsKatie Morgan, Anna Bryans, Filip Brzeszczyński, et al.Journal of Medicinal Chemistry|November 1, 1991
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effectsC M Maragos, D Morley, D A Wink, et al.World Journal of Gastroenterology|August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19Angus K Jacobs, Steven D Morley, Kay Samuel, et al.Journal of Clinical Medicine|June 28, 2023
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In VitroKatie Morgan, Steven D Morley, Arslan K Raja, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Design of selective Cathepsin inhibitorsPaul A Bethel, Stefan Gerhardt, Emma V Jones, et al.Pageof 16